BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16047337)

  • 41. Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling.
    Kumanogoh A; Watanabe C; Lee I; Wang X; Shi W; Araki H; Hirata H; Iwahori K; Uchida J; Yasui T; Matsumoto M; Yoshida K; Yakura H; Pan C; Parnes JR; Kikutani H
    Immunity; 2000 Nov; 13(5):621-31. PubMed ID: 11114375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells.
    Soro PG; Morales-A P; Martínez-M JA; Morales-A S; Copín SG; Marcos MA; Gaspar ML
    J Immunol; 1999 Jul; 163(2):611-7. PubMed ID: 10395648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD72 is an inhibitory pattern recognition receptor that recognizes ribosomes and suppresses production of anti-ribosome autoantibody.
    Akatsu C; Tsuneshige T; Numoto N; Long W; Uchiumi T; Kaneko Y; Asano M; Ito N; Tsubata T
    J Autoimmun; 2024 Jun; 146():103245. PubMed ID: 38754236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD40 preferentially costimulates activation of CD4+ T lymphocytes.
    Cayabyab M; Phillips JH; Lanier LL
    J Immunol; 1994 Feb; 152(4):1523-31. PubMed ID: 7509825
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation.
    Pan C; Baumgarth N; Parnes JR
    Immunity; 1999 Oct; 11(4):495-506. PubMed ID: 10549631
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD40 stimulation provides an IFN-gamma-independent and IL-4-dependent differentiation signal directly to human B cells for IgE production.
    Zhang K; Clark EA; Saxon A
    J Immunol; 1991 Mar; 146(6):1836-42. PubMed ID: 1706382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular interactions regulate BCR signal inhibition by CD22 and CD72.
    Nitschke L; Tsubata T
    Trends Immunol; 2004 Oct; 25(10):543-50. PubMed ID: 15364057
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B.
    Berberich I; Shu GL; Clark EA
    J Immunol; 1994 Nov; 153(10):4357-66. PubMed ID: 7525701
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of germinal center B cell differentiation. Role of the human APO-1/Fas (CD95) molecule.
    Lagresle C; Bella C; Daniel PT; Krammer PH; Defrance T
    J Immunol; 1995 Jun; 154(11):5746-56. PubMed ID: 7538529
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Memory, but not naive, peripheral blood B lymphocytes differentiate into Ig-secreting cells after CD40 ligation and costimulation with IL-4 and the differentiation factors IL-2, IL-10, and IL-3.
    Kindler V; Zubler RH
    J Immunol; 1997 Sep; 159(5):2085-90. PubMed ID: 9278293
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antigen receptor-mediated B cell death is blocked by signaling via CD72 or treatment with dextran sulfate and is defective in autoimmunity-prone mice.
    Nomura T; Han H; Howard MC; Yagita H; Yakura H; Honjo T; Tsubata T
    Int Immunol; 1996 Jun; 8(6):867-75. PubMed ID: 8671676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular control of B lymphocyte growth and differentiation.
    Banchereau J; Brière F; Liu YJ; Rousset F
    Stem Cells; 1994 May; 12(3):278-88. PubMed ID: 7521239
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allele-specific expression of the mouse B-cell surface protein CD72 on T cells.
    Robinson WH; Landolfi MM; Parnes JR
    Immunogenetics; 1997; 45(3):195-200. PubMed ID: 8995186
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased mutations of CD72 transcript in B-lymphocytes from adolescent patients with systemic lupus erythematosus.
    Kaneko U; Toyabe S; Hara M; Uchiyama M
    Pediatr Allergy Immunol; 2006 Dec; 17(8):565-71. PubMed ID: 17121583
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD19 regulation of human B cell responses. B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used.
    Callard RE; Rigley KP; Smith SH; Thurstan S; Shields JG
    J Immunol; 1992 May; 148(10):2983-7. PubMed ID: 1374445
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemokinin-1 activates the MAPK pathway and enhances B cell proliferation and antibody production.
    Wang W; Li Q; Zhang J; Wu H; Yin Y; Ge Q; Zhang Y
    J Immunol; 2010 Apr; 184(7):3590-7. PubMed ID: 20208012
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of interleukin 4-promoted CD23 production in human B lymphocytes by transforming growth factor-beta, interferons or anti-CD19 antibody is overriden on engaging CD40.
    Gordon J; Katira A; Strain AJ; Gillis S
    Eur J Immunol; 1991 Aug; 21(8):1917-22. PubMed ID: 1714394
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway.
    Kansas GS; Tedder TF
    J Immunol; 1991 Dec; 147(12):4094-102. PubMed ID: 1721639
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Signaling through CD19, Fc receptors or transforming growth factor-beta: each inhibits the activation of resting human B cells differently.
    Barrett TB; Shu GL; Draves KE; Pezzutto A; Clark EA
    Eur J Immunol; 1990 May; 20(5):1053-9. PubMed ID: 1694130
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Constitutive CD40 Signaling Calibrates Differentiation Outcomes in Responding B Cells via Multiple Molecular Pathways.
    Basu S; Kaw S; D'Souza L; Vaidya T; Bal V; Rath S; George A
    J Immunol; 2016 Aug; 197(3):761-70. PubMed ID: 27342845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.